0000950170-24-042297.txt : 20240405
0000950170-24-042297.hdr.sgml : 20240405
20240405163313
ACCESSION NUMBER: 0000950170-24-042297
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240329
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Slebir John L
CENTRAL INDEX KEY: 0001475990
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 24826979
MAIL ADDRESS:
STREET 1: C/O VIVUS, INC.
STREET 2: 351 EAST EVELYN AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
3
1
ownership.xml
3
X0206
3
2024-03-29
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001475990
Slebir John L
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 720
EMERYVILLE
CA
94608
false
true
false
false
SVP General Counsel
Common Stock
10085
D
Stock Option (Right to Buy)
9.29
2028-06-27
Common Stock
300000
D
Stock Options (Right to Buy)
12.74
2029-02-09
Common Stock
80000
D
Restricted Stock Unit
Common Stock
14000
D
Stock Options (Right to Buy)
11.12
2030-02-15
Common Stock
88000
D
Stock Options (Right to Buy)
12.48
2031-02-14
Common Stock
70000
D
Restricted Stock Unit
Common Stock
50000
D
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of June 28, 2021, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
/s/ JOHN SLEBIR
2024-04-05